Richard Bernstein Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.85M Hold
3,904
0.05% 91
2025
Q4
$1.82M Sell
3,904
-387
-9% -$180K 0.05% 75
2025
Q3
$1.83M Sell
4,291
-7,048
-62% -$2.73M 0.05% 101
2025
Q2
$4.34M Hold
11,339
0.11% 83
2025
Q1
$3.92M Sell
11,339
-510
-4% -$164K 0.09% 102
2024
Q4
$3.56M Hold
11,849
0.08% 135
2024
Q3
$4.82M Hold
11,849
0.1% 79
2024
Q2
$3.81M Buy
11,849
+2
+0% +$650 0.08% 100
2024
Q1
$3.95M Hold
11,847
0.08% 90
2023
Q4
$3.21M Buy
11,847
+7
+0.1% +$1.73K 0.07% 121
2023
Q3
$2.91M Sell
11,840
-2,183
-16% -$597K 0.07% 108
2023
Q2
$4.26M Hold
14,023
0.09% 68
2023
Q1
$3.7M Hold
14,023
0.08% 96
2022
Q4
$3.36M Hold
14,023
0.08% 111
2022
Q3
$2.58M Hold
14,023
0.06% 141
2022
Q2
$2.36M Hold
14,023
0.05% 161
2022
Q1
$3.51M Hold
14,023
0.07% 145
2021
Q4
$3.6M Buy
+14,023
New +$3.43M 0.07% 146

Other funds holding HCA

Richard Bernstein Advisors's HCA Position: Q1 2026 in Review

Richard Bernstein Advisors held its HCA Healthcare (HCA) position steady in Q1 2026 at 3,904 shares worth $1.85M. The position accounts for 0.05% of the portfolio, ranked #91.

Richard Bernstein Advisors first reported a position in HCA in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.82M in Q3 2024. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Richard Bernstein Advisors held 3,904 shares of HCA Healthcare worth $1.85M as of Q1 2026.
  • Richard Bernstein Advisors left its HCA Healthcare share count unchanged in Q1 2026.
  • HCA Healthcare made up 0.05% of Richard Bernstein Advisors's portfolio in Q1 2026, its #91 holding.
  • Richard Bernstein Advisors first reported a position in HCA Healthcare in Q4 2021 and has held it in 18 quarters since.
  • Richard Bernstein Advisors's HCA Healthcare position peaked at $4.82M in Q3 2024.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Richard Bernstein Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.